Clinical trial

Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

NCT07631611

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-01-01

PhaseN/A

Study timeline

Study start (actual)2016-01-01Date precision: day

Registry last updated2026-06-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Tumorsunresolved

Metastatic Cancer to Liverunresolved

Metastatic Cancer to the Boneunresolved

Metastatic Cancer to the Lungunresolved

Brain Metastasisunresolved

Metastatic Cancersunresolved

Immune Checkpoint Inhibitorsunresolved

Tumor Immune Microenvironmentunresolved

Interventions

Sponsors & collaborators

Wenlong Zhong, MDlead sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitycollaborator

Third Affiliated Hospital, Sun Yat-Sen Universitycollaborator

First Affiliated Hospital of Chongqing Medical Universitycollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07631611 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.